Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001824293-25-000089
Filing Date
2025-07-11
Accepted
2025-07-11 16:17:39
Documents
4
Period of Report
2025-08-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2025proxystatement.htm DEF 14A 556514
2 GRAPHIC image_0a.jpg GRAPHIC 24263
3 GRAPHIC imagea.jpg GRAPHIC 71160
4 GRAPHIC proxycard2a.jpg GRAPHIC 111322
  Complete submission text file 0001824293-25-000089.txt   842864
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI Bio, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40034 | Film No.: 251119183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)